Leap Therapeutics (LPTX) Misses Q2 EPS by 40c
Leap Therapeutics (NASDAQ: LPTX) reported Q2 EPS of ($0.40), $0.40 worse than the analyst estimate of $0.00.
For earnings history and earnings-related data on Leap Therapeutics (LPTX) click here.
Leap Therapeutics (NASDAQ: LPTX) reported Q2 EPS of ($0.40), $0.40 worse than the analyst estimate of $0.00.
For earnings history and earnings-related data on Leap Therapeutics (LPTX) click here.